Close Menu

Golden Helix

The Children's Hospital of Philadelphia has named Toumy Guettouche a senior scientist and director of sequencing within CHOP's Center for Applied Genomics. He reports to Hakon Hakonarson, who heads the center.

Andrew Morris has joined SQI Diagnostics' board of directors.

James Lupski has been named a fellow of the American Academy of Arts and Sciences.

Bioinformatics firm Golden Helix has hired Andreas Scherer to be its new president and CEO.
Scherer has managed large global software services businesses, and he started his executive career at AOL/Netscape.

Golden Helix, a bioinformatics software and services vendor, is expanding its life science research-centric business to include focused solutions for customers in the clinical genomics, pharmacogenomics, and diagnostics markets.

NEW YORK (GenomeWeb News) — In a 1989 piece in Rolling Stone about "the Net" and its future impact on everyday lives, science fiction writer William Gibson avoided making any sweeping predictions.

Increasing activity from sequencing vendors and other new players, as well as a flurry of activity around clinical data analysis software and the commercialization of a number of open source tools were the key trends in the bioinformatics community in 2012.

BioCyc 16.5 is available here.

Several bioinformatics companies who signed on to Illumina’s BaseSpace program released their applications for the cloud infrastructure this week at the American Society of Human Genetics conference.

Golden Helix has released GenomeBrowse, a free genomic visualization and annotation tool for DNA and RNA sequence data.

Pages

Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.

In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.